Print

ANRS VAC 04 bis

A Phase I Clinical Trial to Evaluate the Effect of Reinjection of the VAC 04 Lipopeptides, on the Kinetics of the Cellular Immune Responses in Healthy HIV-1 Uninfected Adult Participants

Trial Details:

I Completed
French National Agency for Research on AIDS and viral hepatitis (ANRS) December 01, 1998
LIPO-6 6 lipopeptides containing CTL epitopes from the Env, Gag and Nef B
LIPO-6 Protein
France 23
http://www.anrs.fr/